Financials • Finance: Consumer Services
$27.95 ▼ -0.92
(-3.19%)
MKT CAP: $10.93B • VOL: 3.65M
52W L $16 52W H $36
ROARABLE / RQD
D- • 42/100
PIOTROSKI
6 / 9
CHYM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.19B | $1.67B | $1.28B |
| YoY Revenue Growth % | +30.7% | +30.9% | — |
| Gross Profit | $1.92B | $1.47B | — |
| Gross Margin % | 88.0% | 87.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.04B | -$62.2M | -$235.8M |
| Operating Margin % | -47.6% | -3.7% | -18.4% |
| Net Income (GAAP) | -$1.01B | -$25.3M | -$203.2M |
| EBITDA (Normalized) | -$961.3M | -$2.0M | -$189.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $52.8M | $64.1M | -$156.6M |
| Capital Expenditures (CapEx) | $98.4M | $75.3M | $57.5M |
| Free Cash Flow (FCF) | -$45.6M | -$11.2M | -$214.1M |
| FCF Margin % | -2.1% | -0.7% | -16.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | -5.1% |
| Cash & Short-Term Equivalents | $466.3M | $337.7M | — |
| Total Debt (Short + Long Term) | $253.3M | $225.7M | $1.41B |
| Total Stockholders' Equity | $1.40B | -$1.93B | $2.89B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CHYM.